Literature DB >> 18700632

Study on CD4 cell responses in HIV infected subjects in Nepal.

B R Tiwari1, P Ghimire, S Malla.   

Abstract

HIV infection is characterized by gradual deterioration of immune function mainly the CD4 cells. This study was conducted with the objectives to evaluate the kinetics of CD4 cell depletion and duration of HIV infection and the role of ART in improving CD4 cell levels specifically in Nepalese HIV patients. During April 2005 to March 2006, all together 220 blood samples collected from 110 HIV patients visiting National Public Health Laboratory (NPHL), Kathmandu, were analyzed for CD4 cell count using standard protocol. CD4 cell count before and after starting of anti-retro viral therapy showed significant association (P<0.05). The results of this study clearly indicated that antiretroviral therapy has been playing a role in maintenance CD4 cell counts in HIV infected patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18700632

Source DB:  PubMed          Journal:  Nepal Med Coll J


  4 in total

1.  CD4 Cell Counts, Lipid Profile, and Oral Manifestations in HIV-Infected and AIDS Patients.

Authors:  Koduri Sridevi; Saka Malathi; Chalapathi Kv; Chowdary Nagarjuna G; M Gayathri; G Eswar Chand; Abhishek Singh Nayyar
Journal:  Front Dent       Date:  2019-12-20

2.  Oral manifestations of HIV in children receiving anti-retroviral therapy in Hyderabad, India.

Authors:  P V Baghirath; A B Krishna; A Gannepalli; M M Ali
Journal:  Eur Arch Paediatr Dent       Date:  2013-06-13

3.  CD4 cell counts and oral manifestations in HIV infected and AIDS patients.

Authors:  Mvr Ratnam; Abhishek Singh Nayyar; D Santhosh Reddy; B Ruparani; K V Chalapathi; Sania Md Azmi
Journal:  J Oral Maxillofac Pathol       Date:  2018 May-Aug

4.  Response to First-Line Antiretroviral Therapy Among PLHIV from a High-Risk, Low-Prevalence Setting.

Authors:  Shahria Mohammad Rashed Ul Islam; Munira Jahan; Afzalun Nessa; Shahina Tabassum
Journal:  J Int Assoc Provid AIDS Care       Date:  2019 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.